Coinspeaker Gilead Sciences (GILD) Stock Rose 1.5% Yesterday on Remdesivir $7 Billion Sales PrognosisAccording to SVB Leerink analyst Geoffrey Porges, remdesivir price is likely to be $5,000 per course in the US, $4,000 per course in Europe, and around $2,000 in other markets. Gilead Sciences (GILD) stock keeps rising.Gilead Sciences (GILD) Stock Rose 1.5% Yesterday on Remdesivir $7 Billion Sales Prognosis